This invention relates to 4-aryloxy-1,2,3,4-tetrahydro- isoquinolines of the formula
where Y is hydrogen and alkoxy; X is hydrogen, cyano, benzoyl, trifluoromethyl, phenyl, halogen, alkyl, alkoxy and nitro; R is hydrogen and alkyl; R, is hydrogen, alkyl, aralkyl,
and CO2R4, where R4 is aryl and alkyl; R2 and R3 are the same or different and are hydrogen and alkyl or R2 and R3 are fused together to form a pyrrolidino or a piperidino ring substituent; and m is an integer of 1 or 2; n is an integer of 2 or 3; and a pharmaceutically acceptable acid addition salt thereof.
本发明涉及 4-芳氧基-1,2,3,4-四氢-
异喹啉,其式为
其中 Y 是氢和烷氧基;X 是氢、
氰基、苯甲酰基、三
氟甲基、苯基、卤素、烷基、烷氧基和硝基;R 是氢和烷基;R, 是氢、烷基、芳烷基、
和 CO2R4,其中 R4 是芳基和烷基;R2 和 R3 相同或不同,并且是氢和烷基或 R2 和 R3 融合在一起形成
吡咯烷或
哌啶环取代基;以及 m 是 1 或 2 的整数;n 是 2 或 3 的整数;及其药学上可接受的酸加成盐。